Reported 2,950,000 shares, up 2,620,000 (793.9%) from the prior quarter.
Reported value 615.3%; share count 793.9% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 10906000 |
| 2022-03-31 | 5835000 |
| 2022-06-30 | 3779000 |
| 2022-09-30 | 5292000 |
| 2022-12-31 | 2924081 |
| 2023-03-31 | 2042107 |
| 2023-06-30 | 0 |
| 2026-03-31 | 14562000 |
| 2026-06-30 | 6045600 |
| 2026-09-30 | 43247000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Added | 2,950,000 | +2,620,000 (793.9%) | 1.92% | $43,247,000 | 2026-11-16 | |
| Q2 2026 | Reduced | 330,000 | -570,000 (-63.3%) | 0.29% | $6,045,600 | 2026-08-14 | |
| Q1 2026 | New | 900,000 | +900,000 (0.0%) | 0.62% | $14,562,000 | 2026-05-15 | |
| Q2 2023 | Reduced | 0 | -678,441 (-100.0%) | 0 | $0 | 2023-08-14 | |
| Q1 2023 | Unchanged | 678,441 | 0 (0.0%) | 0.07% | $2,042,107 | 2023-05-15 | |
| Q4 2022 | Unchanged | 678,441 | 0 (0.0%) | 0.09% | $2,924,081 | 2023-02-14 | |
| Q3 2022 | Unchanged | 678,441 | 0 (0.0%) | 0.16% | $5,292,000 | 2022-11-14 | |
| Q2 2022 | Unchanged | 678,441 | 0 (0.0%) | 0.13% | $3,779,000 | 2022-08-15 | |
| Q1 2022 | Reduced | 678,441 | -21,559 (-3.1%) | 0.18% | $5,835,000 | 2022-05-16 | |
| Q4 2021 | Unchanged | 700,000 | 0 (0.0%) | 0.35% | $10,906,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
299 managers reported ERASCA INC for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| Frazier Life Sciences Management L P | Added | 29,475,188 | +4,500,000 | 10.72% | $432,106,256 | 10 qtrs |
| BlackRock Inc | Added | 23,736,078 | +2,581,932 | < 0.01% | $347,970,906 | 9 qtrs |
| RTW INVESTMENTS LP | Added | 22,446,754 | +4,500,000 | 3.32% | $329,069,414 | 4 qtrs |
| VR Adviser LLC | Added | 20,089,932 | +2,198,120 | 14.31% | $294,518,403 | 10 qtrs |
| T Rowe Price Investment Management Inc | Reduced | 17,192,148 | -3,993,691 | 0.18% | $252,037,000 | 10 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 13,905,796 | +2,503,597 | < 0.01% | $203,858,969 | 3 qtrs |
| STATE STREET CORPORATION | Added | 13,821,643 | +1,637,088 | < 0.01% | $202,625,286 | 21 qtrs |
| Siren L L C | Added | 13,197,781 | +1,800,000 | 4.57% | $193,479,469 | 9 qtrs |
| Capital World Investors | Added | 9,361,401 | +8,656,799 | 0.02% | $137,238,139 | 2 qtrs |
| PRICE T ROWE ASSOCIATES INC MD | Added | 8,652,671 | +2,380,163 | 0.01% | $126,849,000 | 17 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 2,950,000
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.